Berberina: differenze tra le versioni

Contenuto cancellato Contenuto aggiunto
Atarubot (discussione | contributi)
template citazione; rinomina/fix nomi parametri
Riga 53:
 
Recentemente viene studiato per le sue documentate proprietà:
* anticancro<ref>{{Cita pubblicazione|autore= Sun Y, Xun K, Wang Y, Chen X |titolo= A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs |rivista= Anticancer Drugs |volume= 20 |numero= 9 |pp= 757–69 |data= October 2009 |pmid= 19704371 | doi = 10.1097/CAD.0b013e328330d95b }}</ref><ref>{{Cita pubblicazione| vauthors coautori= Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y |titolo= Berberine and Coptidis Rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations |rivista= Journal of Ethnopharmacology |volume= 126 |numero= 1 |pp= 5–17 |data= August 2009 |pmid= 19686830 | doi = 10.1016/j.jep.2009.08.009 }}</ref> <ref>{{Cita pubblicazione|autore= Serafim TL, Oliveira PJ, Sardao VA, Perkins E, Parke D, Holy J |titolo= Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line |rivista= Cancer Chemotherapy and Pharmacology |volume= 61 |numero= 6 |pp= 1007–18 |data= May 2008 |pmid= 17661039 | doi = 10.1007/s00280-007-0558-9 }}</ref><ref>{{Cita pubblicazione|autore= Pinto-Garcia L, Efferth T, Torres A, Hoheisel JD, Youns M |titolo= Berberine Inhibits Cell Growth and Mediates Caspase-Independent Cell Death in Human Pancreatic Cancer Cells |rivista= Planta Medica |volume= 76 |numero= 11 |pp= 1155–61 |data= May 2010 |pmid= 20455200 | doi = 10.1055/s-0030-1249931 }}</ref><ref>{{Cita pubblicazione|autore= Ho YT, Lu CC, Yang JS, Chiang JH, Li TC, Ip SW, Hsia TC, Liao CL, Lin JG, Wood WG, Chung JG |titolo= Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells |rivista= Anticancer Research |volume= 29 |numero= 10 |pp= 4063–70 |data= October 2009 |pmid= 19846952 |url= http://ar.iiarjournals.org/cgi/pmidlookup?view=long&pmid=19846952 }}</ref><ref>{{Cita pubblicazione|autore= Ho YT, Lu CC, Yang JS, Chiang JH, Li TC, Ip SW, Hsia TC, Liao CL, Lin JG, Wood WG, Chung JG |titolo= Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells |rivista= Anticancer Research |volume= 29 |numero= 10 |pp= 4063–70 |data= October 2009 |pmid= 19846952 |url= http://ar.iiarjournals.org/cgi/pmidlookup?view=long&pmid=19846952 }}</ref><ref>{{Cita pubblicazione| vauthors coautori= Auyeung KK, Ko JK |titolo= Coptis chinensis inhibits hepatocellular carcinoma cell growth through nonsteroidal anti-inflammatory drug-activated gene activation |rivista= International journal of molecular medicine |volume= 24 |numero= 4 |pp= 571–7 |data= October 2009 | pmid = 19724899 | doi = 10.3892/ijmm_00000267 }}</ref><ref>{{Cita pubblicazione|autore= Tang F, Wang D, Duan C, Huang D, Wu Y, Chen Y, Wang W, Xie C, Meng J, Wang L, Wu B, Liu S, Tian D, Zhu F, He Z, Deng F, Cao Y |titolo= Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567 |rivista= The Journal of Biological Chemistry |volume= 284 |numero= 40 |pp= 27456–66 |data= October 2009 |pmid= 19651779 | pmc = 2785675 | doi = 10.1074/jbc.M109.033795 }}</ref>
 
*cardiologiche,<ref>{{Cita pubblicazione|autore= Qi MY, Feng Y, Dai DZ, Li N, Cheng YS, Dai Y |titolo= CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity |rivista= Acta Pharmacol Sin |volume= 31 |numero= 2 |pp= 165–74 |data= February 2010 |pmid= 20139899 | pmc = 4002834 | doi = 10.1038/aps.2009.180 |url= http://www.nature.com/aps/journal/v31/n2/abs/aps2009180a.html }}</ref><ref>{{Cita pubblicazione|autore= Huang WM, Yan H, Jin JM, Yu C, Zhang H |titolo= Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs |rivista= Chinese Medical Journal |volume= 105 |numero= 12 |pp= 1014–9 |data= December 1992 |pmid= 1299549 }}</ref><ref>{{Cita pubblicazione|autore= Riccioppo Neto F |titolo= Electropharmacological effects of berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit |rivista= British Journal of Pharmacology |volume= 108 |numero= 2 |pp= 534–7 |data= February 1993 |pmid= 8448600 | pmc = 1908004 | doi = 10.1111/j.1476-5381.1993.tb12836.x }}</ref><ref>{{Cita pubblicazione|autore= Marin-Neto JA, Maciel BC, Secches AL, Gallo Júnior L |titolo= Cardiovascular effects of berberine in patients with severe congestive heart failure |rivista= Clinical Cardiology |volume= 11 |numero= 4 |pp= 253–60 |data= April 1988 |pmid= 3365876 | doi = 10.1002/clc.4960110411 }}</ref><ref>{{Cita pubblicazione|autore= Zeng XH, Zeng XJ, Li YY |titolo= Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy |rivista= The American Journal of Cardiology |volume= 92 |numero= 2 |pp= 173–6 |data= July 2003 |pmid= 12860219 | doi = 10.1016/S0002-9149(03)00533-2 }}</ref><ref>Wu M., Wang J., Liu L.-T. "Advance of studies on anti-atherosclerosis mechanism of berberine", Chinese Journal of Integrative Medicine 2010 16:2 (188-192)</ref><ref>{{Cita pubblicazione|autore= Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY |titolo= The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest |rivista= Phytomedicine |volume= 17 |numero= 6 |pp= 436–40 |data= October 2009 |pmid= 19800775 | doi = 10.1016/j.phymed.2009.08.012 }}</ref>